S. 1784 · 119th Congress (2025–2027)
MAPS Act
This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains.
In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) of greatest priority for providing health care and at high risk of shortage, (3) the shortage of which would adversely affect patients with chronic conditions, and (4) that the Department of Defense (DOD) determines to be critical for military preparedness. The FDA must update the list at least every two years.
Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies.
Additionally, the Department of Health and Human Services, in coordination with other agencies, must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress.
Finally, DOD must report to Congress every 180 days on the drugs DOD purchased that were manufactured in or sourced from China.
Show official title
A bill to improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 1784’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Gary C. Peters (D-MI)
- Cosponsors
7 cosponsors
6 original · 1 later
4 R · 2 D · 1 I
- Sen. Tom Cotton (R-AR)· Original · May 15, 2025
- Sen. Joni Ernst (R-IA)· Original · May 15, 2025
- Sen. Angus S. King Jr. (I-ME)· Original · May 15, 2025
- Sen. Tim Kaine (D-VA)· Original · May 15, 2025
- Sen. James Lankford (R-OK)· Original · May 15, 2025
- Sen. Rick Scott (R-FL)· Original · May 15, 2025
- Sen. Elissa Slotkin (D-MI)· Later · Nov 7, 2025
- Policy area
- Health
- Subjects
- Computer security and identity theft
- Congressional oversight
- Data collection, sharing, protection
- Government information and archives
- Manufacturing
- Prescription drugs
- Strategic materials and reserves
- Supply chain
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
- SenateHealth, Education, Labor, and PensionsReferred May 15, 2025 · Hearings by (full committee) Mar 19, 2026
Mar 19, 2026 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
MAPS Act
Display title, Short title · Introduced in Senate
Mapping America's Pharmaceutical Supply Act
Short title · Introduced in Senate
A bill to improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.
Official title · Introduced in Senate